INTERNATIONAL PATENT: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, 서울대학교산학협력단 FILES APPLICATION FOR "IMMUNOGENIC COMPOSITION COMPRISING MALONATE SEMIALDEHYDE DECARBOXYLASE (MSAD) AND VACCINE COMPOSITION FOR PREVENTING OR TREATING NONTUBERCULOUS MYCOBACTERIA INFECTION, COMPRISING SAME"

GENEVA, March 10 -- SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (1 Gwanak-ro,Gwanak-gu,Seoul 08826), 서울대학교산학협력단 (서울특별시관악구관악로 1) filed a patent application (PCT/KR2025/012997) for "IMMUNOGENIC COMPOSITION COMPRISING MALONATE SEMIALDEHYDE DECARBOXYLASE (MSAD), AND VACCINE COMPOSITION FOR PREVENTING OR TREATING NONTUBERCULOUS MYCOBACTERIA INFECTION, COMPRISING SAME" on Aug 26, 2025. With publication no. WO/2026/049474, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, w...